en

Past events

  • 2025-07-25T13:00:00+02:00
  • 2025-07-25T15:30:00+02:00
July

25

Friday

Jul 25, 2025 from 01:00 PM to 03:30 PM

Topics to be covered: What is autofluorescence (AF)? Primary sources of cellular autofluorescence What is needed to identify AF? AF and dead cell exclusion dyes How does the AF tool work? Practical examples of AF application This session will provide valuable insights into handling autofluorescence in spectral flow cytometry and the advantages offered by the Sony ID7000 system.

  • 2025-07-09T13:00:00+02:00
  • 2025-07-09T15:00:00+02:00
July

9

Wednesday

Jul 09, 2025 from 01:00 PM to 03:00 PM

📅 July 9, 2025 📍 Lehrgebäude (Haus A10), Raum 010.1.01 – University Clinic Bonn 🕐 13:00 – 15:00, followed by snacks and networking We know that many of you couldn’t attend the previous event about this technology, due to a scheduling conflict with another major event. We’re happy to offer this second chance to experience the technology firsthand and connect directly with BD experts. This event is a great opportunity especially for our PIs to discover the powerful capabilities of image cytometry and explore the new potential opened up by our new cell sorter. BD CellView™ uniquely combines flow cytometry with real-time imaging to provide spatial and morphological insights at the single-cell level. 🔗 Register here

  • 2025-06-25T17:00:00+02:00
  • 2025-06-25T19:00:00+02:00
June

25

Wednesday

Jun 25, 2025 from 05:00 PM to 07:00 PM

Join us for another ThemeNight, jointly organized by the Bonner Forum Biomedizin, the Bonn Technology Campus, the TRA Life & Health and the Postdoc-Orga team from the ImmunoSensation Cluster. The the Core Facility Zebrafish will introduce its services and applications on June 25 at 5pm. Speakers: Tobias Lindenberg (Core Manager of the Core Facility Zebrafish, Uni Bonn, Institut of Anatomy) Title: Overview of the Core Facility Zebrafish Knud Esser (Dr. nat. med, UKF Düsseldorf, Translationale Gynäkoonkologie) Titel: In vivo validation of oncological drug candidates targeting metastasis in triple negative breast cancer